HONOLULU–(BUSINESS WIRE)–Bruker (NASDAQ: BRKR) today introduced four important new preclinical imaging systems at the World Molecular Imaging Congress 2015 (WMIC, www.wmis.org) in Honolulu, Hawaii. The novel products launched at WMIC each deliver improved performance and convenience for routine imaging, and open new horizons for advanced translational research, while Bruker’s platform philosophy facilitates multimodal imaging projects. Researchers will gain a more complete picture and deeper
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their…
Status: Recruiting,
Condition Summary: Eye Diseases; Macular Degeneration; Retinal Diseases; Retinal Degeneration; Neovascularization, Pathologic
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Announces New Date for Special Stockholder Meeting
BARCELONA, Spain–(BUSINESS WIRE)–At Ophthalmology Futures European Forum, Salutaris Medical Devices announces 510(k) clearance for device indicated for episcleral brachytherapy.
BARCELLONA, Spagna–(BUSINESS WIRE)–Nel corso dell’Ophthalmology Futures European Forum 2015, Salutaris Medical Devices (SalutarisMD®) ha annunciato che il suo prodotto SMD Sr90-1 Radionuclide Brachytherapy Source (RBS) ha ricevuto l’approvazione 510(k) dalla Food and Drug Administration (FDA) degli Stati Uniti. SMD Sr90-1 RBS è indicato per la brachiterapia episclerale dei tumori e delle escrescenze benigne e va utilizzato nell’ambito di un sistema con applicatore manuale per brachiterapia. “